Skip to main content
NCBI home page
Cancer Cell International logoLink to Cancer Cell International
. 2020 Jul 1;20:282. doi: 10.1186/s12935-020-01381-x

Correction to: Identification of a competing endogenous RNA network associated with prognosis of pancreatic adenocarcinoma

Wanqing Weng 1,2,#, Zhongjing Zhang 1,#, Weiguo Huang 1, Xiangxiang Xu 1, Boda Wu 1,2, Tingbo Ye 1, Yunfeng Shan 3,✉, Keqing Shi 1,2,✉, Zhuo Lin 4,✉
PMCID: PMC7329454  PMID: 32624707

Correction to: Cancer Cell Int (2020) 20:231 10.1186/s12935-020-01243-6

Following publication of the original article [1], the authors notified us that Fig. 6 was incorrectly submitted. The correct figure is presented below.

Fig. 6.

Fig. 6

Open in a new tab

Multi-mRNAs-based classifier. a, b PAAD patients in the training cohort and the validation cohort were classified into predicted low and high-risk groups according to the multi-mRNAs-based classifier. b, d Kaplan–Meier survival analysis of the multi-mRNAs-based classifier was performed. e, g Time-dependent ROC curve and calibration curves of the multi-mRNAs-based classifier in the training cohort. f Time-dependent ROC curve of the multi-mRNAs-based classifier in the validation cohort

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Wanqing Weng and Zhongjing Zhang are first authors

Contributor Information

Yunfeng Shan, Email: shanyunfeng@wmu.edu.cn.

Keqing Shi, Email: skochilly@wmu.edu.cn.

Zhuo Lin, Email: biolinz@163.com.

Reference

  • 1.Weng W, Zhang Z, Huang W, Xu X, Wu B, Ye T, Shan Y, Shi K, Lin Z. Identification of a competing endogenous RNA network associated with prognosis of pancreatic adenocarcinoma. Cancer Cell Int. 2020;20:231. doi: 10.1186/s12935-020-01243-6. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cancer Cell International are provided here courtesy of BMC

RESOURCES